Literature DB >> 28928119

8-Aminoguanosine Exerts Diuretic, Natriuretic, and Glucosuric Activity via Conversion to 8-Aminoguanine, Yet Has Direct Antikaliuretic Effects.

Edwin K Jackson1, Zaichuan Mi2.   

Abstract

8-Aminoguanosine induces diuresis, natriuresis, glucosuria, and antikaliuresis. These effects could be mediated via 8-aminoguanosine's metabolism to 8-aminoguanine. In this study, we tested this hypothesis in anesthetized rats. First, we demonstrated that at 55- to 85-minutes post-i.v. administration, 8-aminoguanosine and 8-aminoguanine (33.5 µmol/kg) significantly increased urine volume [ml/30 min: 8-aminoguanosine from 0.3 ± 0.1 to 0.9 ± 0.1 (mean ± S.E.M.; n = 7); 8-aminoguanine from 0.3 ± 0.1 to 1.5 ± 0.2 (n = 8)], sodium excretion (µmol/30 min: 8-aminoguanosine from 12 ± 5 to 109 ± 21; 8-aminoguanine from 18 ± 8 to 216 ± 31), and glucose excretion (µg/30 min: 8-aminoguanosine from 18 ± 3 to 159 ± 41; 8-aminoguanine from 17 ± 3 to 298 ± 65). Both compounds significantly decreased potassium excretion (µmol/30 min: 8-aminoguanosine from 62 ± 7 to 39 ± 9; 8-aminoguanine from 61 ± 10 to 34 ± 6). Next, we administered 8-aminoguanosine and 8-aminoguanine i.v. (33.5 µmol/kg) and measured renal interstitial (microdialysis probes) 8-aminoguanosine and 8-aminoguanine. The i.v. administration of 8-aminoguanosine and 8-aminoguanine similarly increased renal medullary interstitial levels of 8-aminoguanine [nanograms per milliliter; 8-aminoguanosine from 4 ± 1 to 1025 ± 393 (n = 6), and 8-aminoguanine from 2 ± 1 to 1069 ± 407 (n = 6)]. Finally, we determine the diuretic, natriuretic, glucosuric, and antikaliuretic effects of intrarenal artery infusions of 8-aminoguanosine and 8-aminoguanine (0.1, 0.3, and 1 µmol/kg/min). 8-Aminoguanine increased urine volume and sodium and glucose excretion by the ipsilateral kidney, yet had only mild effects at the highest dose in the contralateral kidney. Intrarenal infusions of 8-aminoguanosine did not induce diuresis, natriuresis, or glucosuria in either the ipsilateral or contralateral kidney, yet decreased potassium excretion in the ipsilateral kidney. Together these data confirm that the diuretic, natriuretic, and glucosuric effects of 8-aminoguanosine are not direct, but require metabolism to 8-aminoguanine. However, 8-aminoguanosine has direct antikaliuretic effects.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28928119      PMCID: PMC5683068          DOI: 10.1124/jpet.117.243758

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

1.  Metabolism of 2',3'-dideoxyinosine (ddI) in human blood.

Authors:  D J Back; S Ormesher; J F Tjia; R Macleod
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

Review 2.  8-nitroguanine, a product of nitrative DNA damage caused by reactive nitrogen species: formation, occurrence, and implications in inflammation and carcinogenesis.

Authors:  Hiroshi Ohshima; Tomohiro Sawa; Takaaki Akaike
Journal:  Antioxid Redox Signal       Date:  2006 May-Jun       Impact factor: 8.401

3.  Assay of excised oxidative DNA lesions: isolation of 8-oxoguanine and its nucleoside derivatives from biological fluids with a monoclonal antibody column.

Authors:  E M Park; M K Shigenaga; P Degan; T S Korn; J W Kitzler; C M Wehr; P Kolachana; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

4.  A rat model of purine nucleoside phosphorylase deficiency.

Authors:  W R Osborne; R W Barton
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

5.  Evaluation of purine nucleoside phosphorylase release as a measure of hepatic endothelial cell injury.

Authors:  C A Brass; M G Mody
Journal:  Hepatology       Date:  1995-01       Impact factor: 17.425

6.  Oxidative damage to DNA during aging: 8-hydroxy-2'-deoxyguanosine in rat organ DNA and urine.

Authors:  C G Fraga; M K Shigenaga; J W Park; P Degan; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  8-Aminoguanosine and 8-Aminoguanine Exert Diuretic, Natriuretic, Glucosuric, and Antihypertensive Activity.

Authors:  Edwin K Jackson; Delbert G Gillespie; Zaichuan Mi
Journal:  J Pharmacol Exp Ther       Date:  2016-09-27       Impact factor: 4.030

8.  Extracellular 2',3'-cAMP is a source of adenosine.

Authors:  Edwin K Jackson; Jin Ren; Zaichuan Mi
Journal:  J Biol Chem       Date:  2009-10-01       Impact factor: 5.157

9.  8-nitroguanosine formation in viral pneumonia and its implication for pathogenesis.

Authors:  Takaaki Akaike; Shinichiro Okamoto; Tomohiro Sawa; Jun Yoshitake; Fumio Tamura; Koji Ichimori; Kiminori Miyazaki; Kazumi Sasamoto; Hiroshi Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-08       Impact factor: 11.205

10.  Rapid measurement of 8-oxo-7,8-dihydro-2'-deoxyguanosine in human biological matrices using ultra-high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Patricia M W Lam; Vilas Mistry; Timothy H Marczylo; Justin C Konje; Mark D Evans; Marcus S Cooke
Journal:  Free Radic Biol Med       Date:  2012-04-15       Impact factor: 7.376

View more
  3 in total

Review 1.  Purine nucleoside phosphorylase as a target to treat age-associated lower urinary tract dysfunction.

Authors:  Lori A Birder; Edwin K Jackson
Journal:  Nat Rev Urol       Date:  2022-09-07       Impact factor: 16.430

2.  Suppressed renoprotective purines in COVID-19 patients with acute kidney injury.

Authors:  Edwin K Jackson; Georgios D Kitsios; Michael Y Lu; Caitlin M Schaefer; Cathy J Kessinger; Bryan J McVerry; Alison Morris; Bernard J C Macatangay
Journal:  Sci Rep       Date:  2022-10-17       Impact factor: 4.996

3.  8-Aminoguanine Induces Diuresis, Natriuresis, and Glucosuria by Inhibiting Purine Nucleoside Phosphorylase and Reduces Potassium Excretion by Inhibiting Rac1.

Authors:  Edwin K Jackson; Zaichuan Mi; Thomas R Kleyman; Dongmei Cheng
Journal:  J Am Heart Assoc       Date:  2018-11-06       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.